Swiss biopharma Idorsia gave out few details Tuesday about a potential $440.8 million (400 million CHF) deal with an unnamed company that would include licensing rights to some of Idorsia’s products …
Read Full Story at source (may require registration)
Community Benefits Program Awards $375K to 18 Regional Recipients for Clean Energy and Wildfire Relief InitiativesLos Angeles, California, Jan. 23,...
West Hollywood, Jan. 23, 2025 (GLOBE NEWSWIRE) -- West Hollywood, California - Amsterdam, Netherlands— Futurola, a global leader in rolling...
A focus on technology and innovation will play a crucial role in achieving economic diversification and agency in the country...
Most Powerful Shelby GT350 in History Arrives for 60th Anniversary 2025 Shelby GT350R The street legal 2025 Shelby GT350R has...
Aalst, Belgium, January 23, 2025 – Ontex Group NV, a leading international developer and producer of personal care products, will...
EllisDon Achieves Platinum in ReNew Canada Magazine's Top100 Projects Report With 20 projects in this year’s report, EllisDon has made...
